med 18

 

322 Section VIII ■ Transfusions

3. Owa JA, Ogunlesi TA. Why are we still doing so many exchange

blood transfusions for neonatal jaundice in Nigeria. World J

Pediatr. 2009;5:51.

4. Gamaleldin R, Iskander I, Seoud I, et al. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia.

Pediatrics. 2011;128:e925.

5. American Academy of Pediatrics. Subcommittee on

Hyperbilirubinemia. Clinical Practice Guideline. Management

of hyperbilirubinemia in the newborn infant 35 or more weeks

gestation. Pediatrics. 2004;114:297.

6. Hansen TW, Nietsch L, Norman E, et al. Reversibility of acute

intermediate phase bilirubin encephalopathy. Acta Paediatr.

2009;98:1689.

7. Watchko JF, Maisels J. Enduring controversies in the management of hyperbilirubinemia in preterm neonates. Semin Fetal

Neonatal Med. 2010;15:136.

8. Van Imhoff DE, Dijk PH, Hulzebos CV, BARTrial study group,

Netherlands Neonatal research Network. Uniform treatment

thresholds for hyperbilirubinemia in preterm infants: background

and synopsis of a national guideline. Early Hum Dev. 2011;87:

521.